Morgan Stanley’s Future Health ESG Corp. Unit FHLTU Stock Holding History

Morgan Stanley’s Portfolio FHLTU Stock Details FHLTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2	Closed	-$19	–	8103
2024 Q1	$19	Hold	2	–	–	﹤0.01%	7727
2023 Q4	$18	Hold	2	–	–	﹤0.01%	7722
2023 Q3	$21	Hold	2	–	–	﹤0.01%	7536
2023 Q2	$20	Hold	2	–	–	﹤0.01%	7585
2023 Q1	$20	Hold	2	–	–	﹤0.01%	7642
2022 Q4	$19	Hold	2	–	–	﹤0.01%	7777
2022 Q3	$0	Hold	2	–	–	﹤0.01%	8225
2022 Q2	$0	Sell	2 -23,244	-100%	-$233K	﹤0.01%	8337
2022 Q1	$232K	Sell	23,246 -50,000	-68%	-$501K	﹤0.01%	5838
2021 Q4	$727K	Buy	73,246 +69,548	+1,881%	+$695K	﹤0.01%	5302
2021 Q3	$37K	Buy	+3,698	New	+$36.8K	﹤0.01%	6854

Morgan Stanley's FHLTU Position: Q2 2024 in Review

Morgan Stanley sold out of Future Health ESG Corp. Unit (FHLTU) in Q2 2024, closing a stake of 2 shares — an estimated $19 sold.

Morgan Stanley first reported a position in FHLTU in Q3 2021 and held it in 11 quarters. The position peaked at $727K in Q4 2021. 0 funds tracked by Wall St. Rank hold FHLTU as of Q2 2024.

Morgan Stanley reported no remaining Future Health ESG Corp. Unit position as of Q2 2024 after selling out during the quarter.
Morgan Stanley sold 2 Future Health ESG Corp. Unit shares in Q2 2024, an estimated $19.
Morgan Stanley first reported a position in Future Health ESG Corp. Unit in Q3 2021 and held it in 11 quarters.
Morgan Stanley's Future Health ESG Corp. Unit position peaked at $727K in Q4 2021.
0 funds tracked by Wall St. Rank held Future Health ESG Corp. Unit as of Q2 2024.

Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.